Pressmeddelande

BioStock: Pricing in focus for Respiratorius ahead of partnering discussions

Cision Publicerad: 21 Nov 2022 08:15

Oncology company Respiratorius are now working on marketing VAL001 with the aim of securing a partnership. A new formulation and the possibility of differentiation from already available products is considered the single most important component to ensure attractive pricing for an upcoming market launch. In this article, BioStock looks at the company’s own pricing analysis and the market potential that it believes the project possesses.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/11/pricing-in-focus-for-respiratorius-ahead-of-partnering-discussions/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Respiratorius

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!